Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

FDA Approves New Range of Respiratory Devices

Jan 27, 2016Mark EdwardsNews

27 January 2016

ASX ANNOUNCEMENT

FDA Approves New Range of Respiratory Devices

Medical Developments International Limited (ASX: MVP) is delighted to announce that it has received approval from the US Food and Drug Administration (FDA) to sell its new range of anti-static respiratory devices in the USA.

The approval represents a significant opportunity to build MDI’s global respiratory business, particularly in the USA. This approval was anticipated and recent marketing efforts means the approval complements a number of Distribution Agreements entered into with North American business partners over the last month. As a consequence, MVP expects to achieve new sales in the near term.

For more information please refer to the following link ASX Announcement_FDA Approves New Range of Respiratory Devices

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter